Singapore markets closed
Straits Times Index
3,266.37 +1.84 (+0.06%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
61,205.44 -1,113.80 (-1.79%) CMC Crypto 200
1,322.19 +22.09 (+1.70%)
Panacea Biotec Limited (PANACEABIO.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
As of 02:45PM IST. Market open.
Currency in INR
Valuation measures4
| Market cap (intra-day) | 8.40B |
| Enterprise value | 6.77B |
| Trailing P/E | 0.61 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.53 |
| Price/book (mrq) | 0.99 |
| Enterprise value/revenue | 1.23 |
| Enterprise value/EBITDA | 10.85 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.74 |
| 52-week change 3 | 14.54% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 202.50 |
| 52-week low 3 | 114.20 |
| 50-day moving average 3 | 139.46 |
| 200-day moving average 3 | 153.08 |
Share statistics
| Avg vol (3-month) 3 | 179.53k |
| Avg vol (10-day) 3 | 102.39k |
| Shares outstanding 5 | 61.25M |
| Implied shares outstanding 6 | 61.3M |
| Float 8 | 14.95M |
| % held by insiders 1 | 73.76% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 19 Sept 2011 |
| Last split factor 2 | 10:1 |
| Last split date 3 | 03 Feb 2003 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -2.12% |
| Operating margin (ttm) | -2.38% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 5.52B |
| Revenue per share (ttm) | 51.72 |
| Quarterly revenue growth (yoy) | 30.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -88.85M |
| Net income avi to common (ttm) | -116.77M |
| Diluted EPS (ttm) | -1.99 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.82B |
| Total cash per share (mrq) | 30.57 |
| Total debt (mrq) | 206.8M |
| Total debt/equity (mrq) | 2.45% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 137.93 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.